Robson de Queiroz Monteiro

Instituição:

Universidade Federal do Rio de Janeiro

Centro:

Centro de Ciências da Saúde

Unidade:

Instituto de Ciências Biomédicas

Departamento:

Docentes/ICB

ORCID:

http://orcid.org/0000-0002-5260-2332


Formação:

  • Universidade do Estado do Rio de Janeiro

    | Pós-Doutorado | 2002 - 2002

  • Universidade Federal do Rio de Janeiro

    Química Biológica | Doutorado | 1997 - 2001

  • Universidade Federal do Rio de Janeiro

    Química Biológica | Mestrado | 1995 - 1997

  • Universidade Federal do Rio de Janeiro

    Farmácia | Graduação | 1990 - 1993
Laboratórios:
Nuvens de Palavras:
Artigos:

(92.37% artigos com DOI)

Titulo DOI Ano
TF/PAR2 Signaling Axis Supports the Protumor Effect of Neutrophil Extracellular Traps (NETs) on Human Breast Cancer Cells 10.3390/cancers16010005 2024
Aspirin Affects MDA-MB-231 Vesicle Production and Their Capacity to Induce Fibroblasts towards a Pro-Invasive State 10.3390/ijms241512020 2023
Atazanavir Is a Competitive Inhibitor of SARS-CoV-2 Mpro, Impairing Variants Replication In Vitro and In Vivo 10.3390/ph15010021 2022
Detachment of Hexokinase II From Mitochondria Promotes Collateral Sensitivity in Multidrug Resistant Chronic Myeloid Leukemia Cells 10.3389/fonc.2022.852985 2022
Apixaban, an orally available anticoagulant, inhibits SARS-CoV-2 replication and its major protease in a non-competitive way 10.1093/jmcb/mjac039 2022
Platelet-monocyte interaction amplifies thromboinflammation through tissue factor signaling in COVID-19 10.1182/bloodadvances.2021006680 2022
Epidermal growth factor receptor regulates fibrinolytic pathway elements in cervical cancer: functional and prognostic implications 10.1590/1414-431x202010754 2021
Recombinant human DNase I for the treatment of cancer-associated thrombosis: A pre-clinical study 10.1016/j.thromres.2021.04.028 2021
Intracerebral hemorrhage associated with vaccine-induced thrombotic thrombocytopenia following ChAdOx1 nCOVID-19 vaccine in a pregnant woman 10.3324/haematol.2021.279407 2021
Fundamentals in Covid-19-Associated Thrombosis: Molecular and Cellular Aspects 10.3389/fcvm.2021.785738 2021
Pisum sativum Defensin 1 Eradicates Mouse Metastatic Lung Nodules from B16F10 Melanoma Cells 10.3390/ijms21082662 2020
Neutrophil Extracellular Traps (NETs) Promote Pro-Metastatic Phenotype in Human Breast Cancer Cells through Epithelial-Mesenchymal Transition 10.3390/cancers12061542 2020
Development of 131I-ixolaris as a theranostic agent: metastatic melanoma preclinical studies 10.1007/s10585-020-10036-0 2020
Characterization and internalization of small extracellular vesicles released by human primary macrophages derived from circulating monocytes 10.1371/journal.pone.0237795 2020
β-Lapachone enhances the antifungal activity of fluconazole against a Pdr5p-mediated resistant Saccharomyces cerevisiae strain 10.1007/s42770-020-00254-9 2020
Extracellular vesicle fingerprinting: the next generation for cancer diagnosis? 10.1038/s41392-020-00385-3 2020
Cellular and Molecular Immunology Approaches for the Development of Immunotherapies against the New Coronavirus (SARS-CoV-2): Challenges to Near-Future Breakthroughs 10.1155/2020/8827670 2020
Interplay Between EGFR and the Platelet-Activating Factor/PAF Receptor Signaling Axis Mediates Aggressive Behavior of Cervical Cancer 10.3389/fonc.2020.557280 2020
Ectophosphatase activity in the triple-negative breast cancer cell line MDA-MB-231 10.1002/cbin.11497 2020
Oral Route Driven Acute Trypanosoma cruzi Infection Unravels an IL-6 Dependent Hemostatic Derangement 10.3389/fimmu.2019.01073 2019
H+-dependent inorganic phosphate transporter in breast cancer cells: Possible functions in the tumor microenvironment 10.1016/j.bbadis.2019.04.015 2019
Novel Aspects of Extracellular Vesicles as Mediators of Cancer-Associated Thrombosis 10.3390/cells8070716 2019
NMR structure determination of Ixolaris and Factor X interaction reveals a noncanonical mechanism of Kunitz inhibition 10.1182/blood.2018889493 2019
IL-1β Blockade Attenuates Thrombosis in a Neutrophil Extracellular Trap-Dependent Breast Cancer Model 10.3389/fimmu.2019.02088 2019
Characterization of inorganic phosphate transport in the triple-negative breast cancer cell line, MDA-MB-231 10.1371/journal.pone.0191270 2018
Ixonnexin from Tick Saliva Promotes Fibrinolysis by Interacting with Plasminogen and Tissue-Type Plasminogen Activator, and Prevents Arterial Thrombosis 10.1038/s41598-018-22780-1 2018
Blood coagulation abnormalities in multibacillary leprosy patients 10.1371/journal.pntd.0006214 2018
Tissue factor mediates microvesicles shedding from MDA-MB-231 breast cancer cells 10.1016/j.bbrc.2018.05.136 2018
Positive crosstalk between EGFR and the TF-PAR2 pathway mediates resistance to cisplatin and poor survival in cervical cancer 10.18632/oncotarget.25748 2018
Protease-activated receptor 2 (PAR2) upregulates granulocyte colony stimulating factor (G-CSF) expression in breast cancer cells 10.1016/j.bbrc.2018.08.169 2018
Crosstalk between BCR-ABL and protease-activated receptor 1 (PAR1) suggests a novel target in chronic myeloid leukemia 10.1016/j.exphem.2018.07.008 2018
Inorganic phosphate transporters in cancer: Functions, molecular mechanisms and possible clinical applications 10.1016/j.bbcan.2018.05.001 2018
Pyrazolyl-Tetrazoles and Imidazolyl-Pyrazoles as Potential Anticoagulants and their Integrated Multiplex Analysis Virtual Screening 10.21577/0103-5053.20180150 2018
Recombinant expression of Ixolaris, a Kunitz-type inhibitor from the tick salivary gland, for NMR studies 10.1016/j.pep.2017.07.012 2017
Tumor-Derived Exosomes Induce the Formation of Neutrophil Extracellular Traps: Implications For The Establishment of Cancer-Associated Thrombosis 10.1038/s41598-017-06893-7 2017
Breast-cancer extracellular vesicles induce platelet activation and aggregation by tissue factor-independent and -dependent mechanisms 10.1016/j.thromres.2017.09.019 2017
1H, 15N and 13C resonance assignments of Ixolaris, a tissue factor pathway inhibitor from the tick salivary gland 10.1007/s12104-017-9766-3 2017
TR47, a PAR1-based peptide, inhibits melanoma cell migration in vitro and metastasis in vivo 10.1016/j.bbrc.2017.11.174 2017
In Vitro Mode of Action and Anti-thrombotic Activity of Boophilin, a Multifunctional Kunitz Protease Inhibitor from the Midgut of a Tick Vector of Babesiosis, Rhipicephalus microplus 10.1371/journal.pntd.0004298 2016
Exploiting the antithrombotic effect of the (pro)thrombin inhibitor bothrojaracin 10.1016/j.toxicon.2016.05.007 2016
Hypoxia regulates the expression of tissue factor pathway signaling elements in a rat glioma model 10.3892/ol.2016.4593 2016
Evoking picomolar binding in RNA by a single phosphorodithioate linkage 10.1093/nar/gkw725 2016
Protease-activated receptor 1 (PAR1): a promising target for the treatment of glioblastoma? 10.21037/tcr.2016.11.30 2016
Thrombocytopenia in Dengue: Interrelationship between Virus and the Imbalance between Coagulation and Fibrinolysis and Inflammatory Mediators 10.1155/2015/313842 2015
99mTc-ixolaris targets glioblastoma-associated tissue factor: In vitro and pre-clinical applications 10.1016/j.thromres.2015.05.032 2015
Salivary Thromboxane A2-Binding Proteins from Triatomine Vectors of Chagas Disease Inhibit Platelet-Mediated Neutrophil Extracellular Traps (NETs) Formation and Arterial Thrombosis 10.1371/journal.pntd.0003869 2015
Identification and Mechanistic Analysis of a Novel Tick-Derived Inhibitor of Thrombin 10.1371/journal.pone.0133991 2015
Thrombomodulin modulates cell migration in human melanoma cell lines 10.1097/CMR.0000000000000035 2014
Expression of tissue factor signaling pathway elements correlates with the production of vascular endothelial growth factor and interleukin-8 in human astrocytoma patients 2014
Structural and Functional Analysis of a Platelet-Activating Lysophosphatidylcholine of Trypanosoma cruzi 10.1371/journal.pntd.0003077 2014
Plasmodium falciparum Infection Induces Expression of a Mosquito Salivary Protein (Agaphelin) That Targets Neutrophil Function and Inhibits Thrombosis without Impairing Hemostasis 10.1371/journal.ppat.1004338 2014
Aegyptin inhibits collagen-induced coagulation activation in vitro and thromboembolism in vivo 10.1016/j.bbrc.2013.05.082 2013
Activation of blood coagulation in cancer: implications for tumor progression 10.1042/BSR20130057 2013
Intercellular transfer of tissue factor via the uptake of tumor-derived microvesicles 10.1016/j.thromres.2013.07.026 2013
Structural Basis for the Interaction of Human β-Defensin 6 and Its Putative Chemokine Receptor CCR2 and Breast Cancer Microvesicles 10.1016/j.jmb.2013.08.001 2013
Desmolaris, a novel Factor XIa anticoagulant from the salivary gland of the vampire bat (Desmodus rotundus) inhibits inflammation and thrombosis in vivo 10.1182/blood-2013-08-517474 2013
Leishmania amazonensis exhibits phosphatidylserine-dependent procoagulant activity, a process that is counteracted by sandfly saliva 10.1590/0074-0276108062013002 2013
Allosteric activation of human ¿-thrombin through exosite 2 by suramin analogs 10.1016/j.abb.2012.02.001 2012
Defibrotide Interferes With Several Steps of the Coagulation-Inflammation Cycle and Exhibits Therapeutic Potential to Treat Severe Malaria 10.1161/ATVBAHA.111.240291 2012
Protease-activated receptor-2 (PAR2) mediates VEGF production through the ERK1/2 pathway in human glioblastoma cell lines 10.1016/j.bbrc.2012.03.140 2012
Inhibition of tissue factor by ixolaris reduces primary tumor growth and experimental metastasis in a murine model of melanoma 10.1016/j.thromres.2012.05.021 2012
Lufaxin, a Novel Factor Xa Inhibitor From the Salivary Gland of the Sand Fly Lutzomyia longipalpis Blocks Protease-Activated Receptor 2 Activation and Inhibits Inflammation and Thrombosis In Vivo 10.1161/ATVBAHA.112.253906 2012
The tick-derived inhibitor Ixolaris prevents tissue factor signaling on tumor cells 10.1111/j.1538-7836.2012.04864.x 2012
Glycoinositolphospholipids from Trypanosomatids Subvert Nitric Oxide Production in Rhodnius prolixus Salivary Glands 10.1371/journal.pone.0047285 2012
Structure and Behavior of Human ¿-Thrombin upon Ligand Recognition: Thermodynamic and Molecular Dynamics Studies 10.1371/journal.pone.0024735 2011
Malignant transformation in melanocytes is associated with increased production of procoagulant microvesicles 10.1160/TH11-03-0143 2011
Alboserpin, a Factor Xa Inhibitor from the Mosquito Vector of Yellow Fever, Binds Heparin and Membrane Phospholipids and Exhibits Antithrombotic Activity 10.1074/jbc.M111.247924 2011
Tissue factor as a target for the treatment of disseminated intravascular coagulation 10.1016/j.thromres.2011.04.006 2011
Increased expression of protease-activated receptor 1 (PAR-1) in human leukemias 10.1016/j.bcmd.2010.12.005 2011
Platelet Activating Factor Blocks Interkinetic Nuclear Migration in Retinal Progenitors through an Arrest of the Cell Cycle at the S/G2 Transition 10.1371/journal.pone.0016058 2011
Venous thrombosis risk: Effects of palm oil and hydrogenated fat diet in rats 10.1016/j.nut.2009.11.027 2011
Tissue factor expression on monocytes from patients with severe dengue fever 10.1016/j.bcmd.2010.08.004 2010
Nitrophorin 2, a factor IX(a)-directed anticoagulant, inhibits arterial thrombosis without impairing haemostasis 10.1160/TH10.1160/TH10-03-0186 2010
Increased expression of tissue factor and protease-activated receptor-1 does not correlate with thrombosis in human lung adenocarcinoma 10.1590/S0100-879X2010007500017 2010
Aegyptin displays high-affinity for the von Willebrand factor binding site (RGQOGVMGF) in collagen and inhibits carotid thrombus formation 10.1111/j.1742-4658.2009.07494.x 2010
Anticoagulant activity of a sulfated galactan: Serpin-independent effect and specific interaction with factor Xa 10.1160/TH09-04-0273 2009
Ixolaris, a tissue factor inhibitor, blocks primary tumor growth and angiogenesis in a glioblastoma model 10.1111/j.1538-7836.2009.03553.x 2009
Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner 10.1016/j.canlet.2009.03.041 2009
Simultaneous tissue factor expression and phosphatidylserine exposure account for the highly procoagulant pattern of melanoma cell lines 10.1097/CMR.0b013e32832e40fe 2009
Lung adenocarcinoma and antiphospholipid antibodies 10.1016/j.autrev.2009.01.010 2009
Structural and thermodynamic analysis of thrombin:suramin interaction in solution and crystal phases 10.1016/j.bbapap.2009.03.011 2009
Evidence for increased expression of tissue factor and protease-activated receptor-1 in human esophageal cancer 10.3892/or_00000393 2009
Blood Coagulation, Inflammation, and Malaria 10.1080/10739680701451516 2008
Serpin-independent anticoagulant activity of a fucosylated chondroitin sulfate 10.1160/TH08-04-0210 2008
Prothrombin fragments containing kringle domains induce migration and activation of human neutrophils 10.1016/j.biocel.2007.09.002 2008
Procoagulant properties of human MV3 melanoma cells 10.1590/S0100-879X2008005000003 2008
Sulfated galactan is a catalyst of antithrombin-mediated inactivation of α-thrombin 10.1016/j.bbagen.2008.05.006 2008
Adenovirus Serotype 5 Hexon Mediates Liver Gene Transfer 10.1016/j.cell.2008.01.016 2008
Ixolaris binding to factor X reveals a precursor state of factor Xa heparin-binding exosite 10.1110/ps.073016308 2007
Suramin counteracts the haemostatic disturbances produced by Bothrops jararaca snake venom 10.1016/j.toxicon.2007.01.002 2007
Plasmodium falciparum-infected erythrocytes induce tissue factor expression in endothelial cells and support the assembly of multimolecular coagulation complexes 10.1111/j.1538-7836.2006.02232.x 2007
On the molecular mechanisms for the highly procoagulant pattern of C6 glioma cells 10.1111/j.1538-7836.2006.01985.x 2006
Counteracting effect of glycyrrhizin on the hemostatic abnormalities induced by Bothrops jararaca snake venom 10.1038/sj.bjp.0706786 2006
Antithrombotic properties of ixolaris, a potent inhibitor of the extrinsic pathway of the coagulation cascade 10.1160/TH06-02-0105 2006
Ecotin modulates thrombin activity through exosite-2 interactions 10.1016/j.biocel.2006.05.001 2006
Platelet-activating factor-like activity isolated from Trypanosoma cruzi 10.1016/j.ijpara.2005.09.016 2006
TARGETING EXOSITES ON BLOOD COAGULATION PROTEASES 2005
Bothrojaracin, a <i>Bothrops jararaca</i> Snake Venom-Derived (Pro)Thrombin Inhibitor, as an Anti-Thrombotic Molecule 10.1159/000092416 2005
Assembly and regulation of prothrombinase complex on B16F10 melanoma cells 10.1016/j.thromres.2004.08.001 2005
Ixolaris: a Factor Xa heparin-binding exosite inhibitor 10.1042/BJ20041738 2005
NEW INSIGHTS INTO CONFORMATIONAL AND FUNCTIONAL STABILITY OF HUMAN alpha-THROMBIN PROBED BY HIGH HYDROSTATIC PRESSURE 2004
Suramin interaction with human α-thrombin: inhibitory effects and binding studies 10.1016/j.biocel.2004.03.007 2004
ASSEMBLY AND REGULATION OF PROTHROMBINASE COMPLEX ON B16F10 MELANOMA CELLS 2003
PROEXOSITE I LIGANDS AS PROBES FOR THE STUDY OF PROTHROMBIN ACTIVATION 2003
Lysophosphatidylcholine Acts as an Anti-hemostatic Molecule in the Saliva of the Blood-sucking Bug Rhodnius prolixus 10.1074/jbc.M212421200 2003
Mechanisms of ouabain toxicity 10.1096/fj.02-0937fje 2003
Subunit Dissociation, Unfolding, and Inactivation of Bothrojaracin, a C-Type Lectin-like Protein from Snake Venom 10.1021/bi020571z 2003
Antithrombotic effect of Glycyrrhizin, a plant-derived thrombin inhibitor 10.1016/j.thromres.2003.10.014 2003
BOTHROJARACIN, A PROEXOSITE I LIGAND, INHIBITS FACTOR Va ACCELERATED PROTHROMBIN ACTIVATION 2002
BOTHROJARACIN INTERACTION WITH PROTHROMBIN 2001
Characterization of bothrojaracin interaction with human prothrombin 10.1110/ps.09001 2001
Proteolytic action of Bothrops jararaca venom upon its own constituents 10.1016/S0041-0101(00)00208-7 2001
Inhibition of Prothrombin Activation by Bothrojaracin, a C-Type Lectin from Bothrops jararaca Venom 10.1006/abbi.2000.2006 2000
Allosteric Changes of Thrombin Catalytic Site Induced by Interaction of Bothrojaracin with Anion-Binding Exosites I and II 10.1006/bbrc.1999.1297 1999
BOTHROPS JARARACA SNAKES PRODUCE SEVERAL BOTHROJARACIN ISOFORMS FOLLOWING AN INDIVIDUAL PATTERN 1998
Variability of bothrojaracin isoforms and other venom principles in individual jararaca (Bothrops jararaca) snakes maintained under seasonally invariant conditions 10.1016/s0041-0101(97)00061-5 1998
DISTINCT BOTHROJARACIN ISOFORMS PRODUCED BY INDIVIDUAL JARARACA (Bothrops jararaca) SNAKES 1997
Identification of Glycyrrhizin as a Thrombin Inhibitor 10.1006/bbrc.1997.6735 1997
Eventos:

(0.00% eventos com DOI)

Titulo DOI Ano
Characterization of in vitro procoagulant mechanisms of the human glioblastoma cell line, A172 2008
Procoagulant properties of melanoma microvesicles suggest their involvement in cancer-associated thrombosis 2008
The insect-derived lipocalin, nitrophorin 2, is a potent antithrombotic agent 2008
Targeting the procoagulant properties of glioma cells: a possible treatment for glioblastoma? 2007
Malignant transformation in melanocytes increases the production of procoagulant microvesicles 2007
Antitumor effect of ixolaris, a FVIIa/tissue factor complex inhibitor, in B16F10 melanoma 2007
Serpin-independent anticoagulant activity of sulfated polysaccharides from marine organisms 2007
Immunity, thrombosis and survival in lung adenocarcinoma patients: a prospective study 2007
Procoagulant properties of U87MG human glioblastoma cells and molecular targets of the anticoagulant and antitumor agent Ixolaris 2007
Increased expression of tissue factor, PAR-1 and interleukin-8 in esophageal cancer patients 2007
Correlation of thrombosis and prothrombotic markers with survival in lung adenocarcinoma patients: a prospective study 2007
Human MV3 melanoma cells display an unusual mechanism for procoagulant activity 2006
Blood coagulation proteins in cancer: increased expression of Tissue Factor and PAR-1 in esophageal cancer 2006
Anticoagulant and antithrombotic properties of Anophelin, a novel anti-thrombin molecule 2006
Sulfated galactan and heparin differ in their preferred pathway of polysaccharide-accelerated inactivation of thrombin by antithrombin 2006
A serpin independent inhibition of coagulation by sulfated polysaccharides from marine organisms 2006
Structural basis for thrombin inhibition by suramin 2006
Counteracting effect of glycyrrhizin on the haemostatic abnormalities induced by Bothrops jararaca snake venom 2006
Putative immunosupressive role of phosphatidylserine-exposing vesicles from B16F10 cells in malignant melanoma establishment 2006
Inhibition of platelet aggregation by a fucosylated chondroitin sulfate from a sea cucumber 2006
Procoagulant activity of three different types of leukemic cell lines 2006
Increased Expression of TF and PAR-1 in esophageal cancer patients 2005
Rat C6 Glioma Cells Express Tissue Factor and Strongly Assemble Blood Procoagulant Complexes 2005
Expression of tissue factor in human monocytes infected by Dengue 2 virus-A possible role in Dengue hemorrhagic fever? 2005
Heparin cofactor II-independent antithrombotic activity of ascidian dermatan sulfates in an arterial thrombosis model in rats 2005
Fucosylated chondroitin sulfate prevents thrombin- and collagen-induced platelet aggregation 2005
Calcium enhances sulfated galactan catalysis of the antithrombin-factor Xa inhibition reaction by a bridging mechanism 2005
The anticoagulant action of a sulfated galactan starts by its initial binding to thrombin instead of antithrombin 2005
Occupancy of active site promotes specific structural and thermodynamic changes in human thrombin 2005
Anticoagulant and Antithrombotic Properties of Ixolaris, a Novel Recombinant FVIIa-Tissue Factor Inhibitor 2005
The Effect of Glycyrrhizin against the Pro-Hemostatic Activities of Bothrops jararaca Snake Venom 2005
Antithrombotic effect of Bothrojaracin, a Bothrops jararaca snake venom-derived (pro)thrombin inhibitor 2005
Prothrombin Fragments Interfere in Human Neutrophil Migration by Modulating Grk-2 and IL-8 Expression 2005
Antithrombotic effect of Bothrojaracin, a snake-derived (pro)thrombin inhibitor 2005
Procoagulant pattern of rat C6 glioma cells: a new model for studying the role of blood coagulation proteins in tumor biology 2005
Platelet activating factor disturbs interkinetic nuclear migration by induction of a checkpoint in the S/G2 transition of the cell cycle in the developing retina 2005
Monocyte activation after Dengue Virus infection: Toll-Like Receptor, Inducible Nitric Oxide Synthase, Bcl-2 and Tissue Factor expression 2005
Blood coagulation proteins in cancer: molecular mechanisms for the highly procoagulant pattern of C6 glioma cells 2005
Blood coagulation proteins in cancer: increased expression of tissue factor and PAR-1 in esophageal cancer 2005
Jarastatin, a Bothrops jararaca venom-derived peptide, is a potent inhibitor of human platelet aggregation 2005
Rat C6 Glioma Cells Express Tissue Factor and Strongly Assemble Blood Procoagulant Complexes 2005
Characterization of procoagulant activity of a human melanoma cell line ? WM-266-4 2005
Propriedades antitrombóticas do Ixolaris, um novo inibidor da via do fator tecidual 2005
Comparative study of snake venoms using maldi tof mass spectrometry as a tool to investigate low mass peptides in complex samples 2004
Ixolaris inhibits tumor-assembled procoagulant enzymatic complexes 2004
Ixolaris: a factor Xa heparin-binding exosite inhibitor 2004
Prothrombin is chemotactic for human neutrophils in a process involving the PKC pathway 2004
Antithrombotic effect of Bothrojaracin, a Bothrops jararaca snake venom-derived (pro)thrombin inhibitor 2004
The effect of Glycyrrhizin against Bothrops jararaca snake venom: evaluation of in vivo pro-hemostatic activities 2004
The effect of Suramin against Bothrops jararaca snake venom: evaluation of in vivo pro-hemostatic activities 2004
Nitric oxide synthase is down-regulated during infection of Rhodnius prolixus salivary glands by Trypanosoma rangeli 2003
Platelet activating factor disturbs interkinetic nuclear migration by induction of a checkpoint in the S/G2 transition of the cell cycle in the developing retina 2003
Platelet activating factor disturbs interkinetic nuclear migration in the developing retina 2003
Prothrombinase complex assembly on B16F10 melanoma cells 2003
Stimulation of differentiation and infectivity of Trypanosoma cruzi by intrinsic lipid 2003
Assembly and regulation of prothrombinase complex on B16F10 melanoma cells 2003
Unfolding, subunit dissociation, and inactivation of C-type lectin-like proteins from snake venom 2002
Bothrojaracin, a proexosite I ligand, inhibits factor Va-accelerated prothrombin activation 2002
Anti-Hemostatic Activities Of Rhodnius prolixus Salivary Glands' Phospholipids. 2002
Antithrombotic effect of glycirrhizin 2002
Stimulation of Leishmania amazonensis and Trypanosoma cruzi infectivity by an intrinsic lipid 2002
Characterization of bothrojaracin interaction with human prothrombin 2001
Characterization of bothrojaracin interaction with human prothrombin 2001
Purification and partial characterization of a C-type Lectin from Bothrops insularis venom 2001
Antithrombotic activity of glycyrrhizin 2001
Bothrojaracin interaction with prothrombin 2001
Bothrojaracin, a thrombin inhibitor from Bothrops jararaca venom: mechanism of action and structural aspects 2000
Purification and partial characterization of a C-type lectin from Bothrops insularis venom 2000
Inhibition of prothrombin activation by bothrojaracin, a C-type lectin from Bothrops jararaca venom 2000
Inhibition of prothrombin activation by bothrojaracin, a C-type lectin from Bothrops jararaca venom 2000
Bothrojaracin, a C-type lectin from Bothrops jararaca venom, inhibits prothrombin activation 2000
Characterization of the ecotin interaction with thrombin 2000
Distinct mechanisms of Urea- and High hydrostatic pressure-induced unfolding of human-a-thrombin 1999
Structural studies of bothrojaracin, a C-type lectin from Bothrops jararaca snake venom 1999
Allosteric changes on thrombin catalytic site induced by interaction with anion-binding exosites I and II 1999
Biological properties of Bothrops insularis (jararaca Ilhoa) venom on blood components 1998
Bothrojaracin interaction with thrombin exosite I plays a major role in the allosteric changes of thrombin's catalytic site 1998
Bothrojaracin produces allosteric changes on thrombin's catalytic site 1998
Proteolytic action of Bothrops jararaca venom upon its own constituents 1998
Effect of Bothrops insularis venom on blood components 1998
Bothrojaracin, a thrombin inhibitor isolated from Bothrops jararaca venom, binds to thrombin's anion-binding exosite producing conformational changes in its catalytic site 1997
Identification of glycyrrhizin as a thrombin inhibitor 1997
Kinetic parameters of anticoagulant activities of low molecular weight heparin (LMWH) 1997
Ação proteolítica do veneno da serpente Bothrops jararaca (jararaca) em seus próprios constituintes 1997
Bothrops jararaca snakes produce several bothrojaracin isoforms following an individual pattern 1997
Analysis of bothrojaracin content in the venom of an individual Bothrops jararaca snake collected over ten months 1996
Seasonal pattern of bothrojaracin isoforms produced by individual Bothrops jararaca (jararaca) snakes 1996
Purification of bothrojaracin in individual Bothrops jararaca snake venoms 1995
Análise da presença de botrojaracina - um inibidor prtéico isolado do veneno de Bothrops jararaca - em venenos individuais 1994
Variation in the individual composition of Bothrops jararaca snake venom 1993
Variabilidade quali-quantitativa da composição dos venenos da espécie Bothrops jararaca 1992
Publicações:
Minha Rede: